Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects
Clinical trial NCT05095168 · COMPLETED
Trial details
- NCT number
- NCT05095168
- Sponsor
- CARE Pharma Shanghai Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2021-11-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.